Transcat Inc
NASDAQ:TRNS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Transcat Inc
NASDAQ:TRNS
|
US |
|
M
|
Morgan Stanley
XBER:DWD
|
US |
|
Italian Wine Brands S.P.A.
MIL:IWB
|
IT |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
Kimberly-Clark Corp
NASDAQ:KMB
|
US |
|
M
|
Max Estates Ltd
NSE:MAXESTATES
|
IN |
|
Vyne Therapeutics Inc
NASDAQ:VYNE
|
US |
|
F
|
Fabasoft AG
XBER:FAA
|
AT |
|
Home REIT PLC
LSE:HOME
|
UK |
|
Gecina SA
PAR:GFC
|
FR |
|
First Commonwealth Financial Corp
NYSE:FCF
|
US |
Wall St Price Targets
TRNS Price Targets Summary
Transcat Inc
According to Wall Street analysts, the average 1-year price target for TRNS is 103.36 USD with a low forecast of 95.95 USD and a high forecast of 110.25 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TRNS's stock price target?
Price Target
103.36
USD
According to Wall Street analysts, the average 1-year price target for TRNS is 103.36 USD with a low forecast of 95.95 USD and a high forecast of 110.25 USD.
What is the Revenue forecast for Transcat Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 6 years is 9%.
What is the Operating Income forecast for Transcat Inc?
Projected CAGR
14%
Over the last 13 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 6 years is 14%.
What is the Net Income forecast for Transcat Inc?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 6 years is 17%.
